Trial intelligence / Profile preview

AMD3100 Mobilization in Healthy Volunteers Previously Mobilized with G-CSF

NCT00075335Phase 2Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Jan 2004
Primary completion
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of plerixafor in hematopoietic stem cell mobilization, sponsored by National Heart, Lung, and Blood Institute. Started Jan 2004; status: completed.

02

Drugs

plerixafor
03

Conditions

hematopoietic stem cell mobilization

Beyond the preview

Go deeper on NCT00075335.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00075335.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call